Inventor
GOSSELIN FRANCIS
US41 patents
⚠️ This page may combine multiple inventors who share the name “GOSSELIN FRANCIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
25 patentsUS10954234B2Mar 23, 2021
Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use
GENENTECH INC6 citations80
US9315471B2Apr 19, 2016
Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
GENENTECH INC12 citations80
US10435378B2Oct 8, 2019
Processes for the preparation of pyrimidinylcyclopentane compounds
GENENTECH INC2 citations72
US9862689B2Jan 9, 2018
Processes for the preparation of pyrimidinylcyclopentane compounds
GENENTECH INC4 citations72
US10781219B2Sep 22, 2020
Process for the preparation of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[F]imidazo[1,2-D][1,4]oxazepin-9-yl)amino) propanamide
GENENTECH INC5 citations71
US11661424B2May 30, 2023
Process for preparing BTK inhibitors
GENENTECH INC1 citations70
US10882864B2Jan 5, 2021
Process for preparing BTK inhibitors
GENENTECH INC3 citations70
US10385058B2Aug 20, 2019
Process for preparing BTK inhibitors
GENENTECH INC3 citations70
US9290458B2Mar 22, 2016
Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof
GENENTECH INC4 citations70
US11969426B2Apr 30, 2024
Pharmaceutical compositions comprising Akt protein kinase inhibitors
GENENTECH INC1 citations68
US11337977B2May 24, 2022
Pharmaceutical compositions comprising Akt protein kinase inhibitors
GENENTECH INC3 citations68
US8895729B2Nov 25, 2014
Process for making thienopyrimidine compounds
GENENTECH INC3 citations60
US9505725B2Nov 29, 2016
Crystalline and mesomorphous forms of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof
GENENTECH INC2 citations59
US12440492B2Oct 14, 2025
Pharmaceutical compositions comprising AKT protein kinase inhibitors
GENENTECH INC0 citations58
US11702452B2Jul 18, 2023
Process for making arylomycin ring analogs
GENENTECH INC0 citations55
US11192924B2Dec 7, 2021
Process for making arylomycin ring analogs
GENENTECH INC0 citations55
US11325912B2May 10, 2022
Regio-selective synthesis of imidazo[1,2-a]pyrimidines
GENENTECH INC0 citations54
US11136330B2Oct 5, 2021
Synthesis of labeled imidazo[1,2-A]pyrimidines
GENENTECH INC0 citations54
US10858324B2Dec 8, 2020
Processes for the preparation of pyrimidinylcyclopentane compounds
GENENTECH INC0 citations51
US11414412B2Aug 16, 2022
Process for the preparation of a medicament
GENENTECH INC0 citations49
US9975856B2May 22, 2018
Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
GENENTECH INC0 citations47
US11999749B2Jun 4, 2024
Synthesis of a bis-mesylate salt of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide and intermediates thereto
GENENTECH INC0 citations43
US12172982B2Dec 24, 2024
Synthesis of quinazoline compounds
GENENTECH INC0 citations41
US12071422B2Aug 27, 2024
Process for synthesis of quinazoline compounds
GENENTECH INC0 citations41
US10329288B2Jun 25, 2019
Process for preparing a compound
GENENTECH INC0 citations36
FORMA TM LLC
4 patentsUS10772874B2Sep 15, 2020
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC6 citations83
US10456382B2Oct 29, 2019
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC7 citations83
US10272072B2Apr 30, 2019
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC11 citations83
US10696692B2Jun 30, 2020
Amido-benzyl sulfone and sulfoxide derivates
FORMA TM LLC6 citations72
HOFFMANN LA ROCHE
3 patentsUS10457648B2Oct 29, 2019
Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds
HOFFMANN LA ROCHE1 citations62
US11780834B2Oct 10, 2023
Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use
HOFFMANN LA ROCHE0 citations58
US10870626B2Dec 22, 2020
Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds
HOFFMANN LA ROCHE0 citations51